Latest Videos
Video
Group 2 PH: The Overlooked Link Between Heart and Lung Health
Dr. Raymond Benza shares key insights from his ongoing work and discusses the evolving landscape of treatment for Group 2 pulmonary hypertension.
Video
New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients
While an estimated 95% of “younger” patients diagnosed with Hodgkin lymphoma are still alive and into survivorship within five years of their diagnosis, their long-term health suffers from the aggressive treatment needed to fight the disease.
Video
Head and Neck Study Presented by Robert Haddad, MD
Dana-Farber's Dr. Robert Haddad says research shows the combination of a PD1 with anti-LAG3 +/- anti-TIM3 does not improve outcomes in metastatic disease, raising the question of whether to look at this combo earlier, in the neoadjuvant setting.
Video
KIM-1 in Kidney Cancer Study Presented by Vincent Xu, MD
Dana-Farber Cancer Institute's D. Wenxin (Vincent) Xu shares research suggesting a blood test measuring levels of the KIM-1 biomarker could help assess the burden of disease in advanced kidney cancer and predict outcomes during first-line treatment.
Video
Marc Machaalani, MD on MAdCAM-1
Kidney cancer research at ESMO25: Dana-Farber's Marc Machaalani, MD, shares 3 key takeaways from his presentation on the protein MAdCAM-1 and its ability to predict outcomes in patients with metastatic renal cell carcinoma.
Video
Paolo Tarantino, MD, PhD, on ADCs
The Next Frontier of Antibody-Drug Conjugate Development - Dana-Farber's Paolo Tarantino, MD, discussed how to optimize the safety of antibody drug conjugates at a session during ESMO25.
Video
ASCENT-03 Study Presented by Sara Tolaney, MD, MPH
Dr. Sara Tolaney details research in The New England Journal of Medicine showing the ADC sacituzumab govitecan improved outcomes for patients with advanced triple-negative #BreastCancer ineligible for immune checkpoint inhibitors.
Video
FLAURA2 Lung Cancer Study Presented by Pasi Jänne, MD, PhD
Dana-Farber Cancer Institute's Dr. Pasi Jänne details FLAURA2 which found first-line osimertinib + platinum pemetrexed chemotherapy improved overall survival vs. monotherapy in EGFR mutated non-small cell lung cancer, including poorer prognosis patients.
Latest Documents
Document
Expanding the Boundaries of Endoluminal Therapies
Building on the established innovations of the Dilumen Platform, the Dilumen EZ1 provides a reliable solution to support advanced endoluminal procedures in the lower gastrointestinal tract.
Document
The Breast Oncology Center at Dana-Farber Brigham Cancer Center held multidisciplinary meetings to discuss recommendations regarding the use of ovarian function suppression and estradiol monitoring in early-stage estrogen receptor positive breast cancer.
Document
Tip Sheet: Caring for Transgender and Gender Diverse Patients
The Breast Oncology Center developed this reference for providers caring for transgender and gender diverse patients in October 2025.
Document
Expert Review: Early Palliative Care as an Adjunct to Disease-Directed Care in Breast Cancer
The Breast Oncology Center developed this reference for providers based on a presentation by James A. Tulsky, MD, given on February 26, 2025.
Latest Articles
News
Board-certified neurologist Peter A. Abdelmalik, M.D., Ph.D., has joined Baptist Health Brain & Spine Care and will serve as director of inpatient general neurology.
News
Board-certified interventional pain management physician Srishti Srivastava, M.D., has joined Baptist Health Brain & Spine Care. She specializes in integrating interventional procedures with complementary medicine to treat pain holistically.
News
Faculty Shares Expertise on Emerging Trends at AAP National Conference
Cedars-Sinai Guerin Children’s faculty showcased their leadership and expertise at the American Academy of Pediatrics (AAP) National Conference in Denver.
News
Long-Term Use of Sleep Supplement Melatonin Linked to Potential Heart Risks
A new study suggests that long-term use of melatonin may carry significant health risks, particularly for the heart.
Latest Courses
Course
Myelopathy Through a Surgeon's Lens
In this CME, Kathryn S. Hoes, MD discusses how to identify anatomic correlates of clinical relevance, define myelopathy accurately, conduct a relevant patient history, interpret key physical examination findings, and recognize key radiographic ...
Course
Updates in Cardiac Transplant, VAD, and Cardiogenic Shock
In this CME, Amanda Ann Hopwood, PA-C, discusses how to explain the role of bloodless medicine in VAD and Transplant, implement improved documentation of cardiogenic shock cases, and analyze patient access through education on transplant ...
Course
In this CME, Stalin Dharmayan, MD, discusses how to explain the need for vascular access, describe the options for vascular access, and implement post-op case for vascular.
Course
The Tip of the Iceberg: A Thorough Workup of Autonomic Dysreflexia
In this CME, Caroline M. Vail, DO, discusses how clinicians can quickly identify typical and atypical symptoms of autonomic dysreflexia (AD) to better prevent it, thus hopefully mitigating cardiovascular comorbidities for patients with ...
